drugset / Trial / NCT03549559
Imaging Histone Deacetylase in the Heart
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.
Timeline
- Start
- 2018-09-07
- Primary completion
- 2026-03-01
- Completion
- 2026-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 11C-Martinostat | Diagnostic / imaging agent | — | Intravenous |